hat
Apre plizyè ane, Biyo-Teknoloji Jeneral Kòporasyon (Biyo-Teknoloji Jeneral Kòporasyon an) te pran sou rechèch la ak devlopman nan dwòg la. Esè klinik yo ke konpayi an te fè sou dwòg la nan 1995 mennen nan dezyèm lage li yo, men Lè sa a, anba Oxandrin (non mak).
eng
After several years, Bio-Technology General Corporation (Bio-Technology General Corporation) took over the research and development of the drug. The clinical trials that the company did on the drug in 1995 lead to its second release, but then under Oxandrin (brand name).